Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Chiesi reports pharmacological profile of CHF-2363

Nov. 21, 1996

Merck & Co. launches Hyzaar in France

Nov. 21, 1996

Potent and selective PAF antagonist from Uriach

Nov. 21, 1996

TBC-11251 enters clinical trials

Nov. 20, 1996

Completion of phase IIa trials with CytoTAb in sepsis

Nov. 19, 1996

ET antagonists revealed by SmithKline Beecham

Nov. 19, 1996

Hyal and The Hospital for Sick Children vascular disease collaboration

Nov. 15, 1996

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

NEP and ECE inhibitors reported by Kali-Chemie

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...